Endocrinology, Vol 124, 2350-2357, Copyright © 1989 by Endocrine Society

ARTICLES

Interleukin-1 alpha exerts glucose-dependent stimulatory and inhibitory effects on islet cell phosphoinositide hydrolysis and insulin secretion

WS Zawalich, KC Zawalich and H Rasmussen
Yale University School of Nursing, New Haven, Connecticut 06536-0740.

Isolated rat islets were incubated with myo-[2-3H]inositol to label their phosphoinositides (PI). Labeling was carried out in the presence of various glucose levels (2.75-10 mM) with or without human recombinant interleukin-1 alpha (IL-1). After the labeling period, insulin release, [3H]inositol efflux, and the accumulation of labeled inositol phosphates in perfused islets were assessed under various conditions. The following major observations were made. 1) In islets labeled for 2 h with [3H]inositol in the presence of 2.75 mM glucose, subsequent perifusion with 5.0 nM IL-1 increased insulin output, [3H]inositol efflux, and [3H]inositol phosphate accumulation in the simultaneous presence of 7 mM, but not 2.75 mM, glucose. 2) Mannoheptulose, a competitive inhibitor of islet glucokinase, blocked the stimulatory effects of IL-1 noted in the presence of 7 mM glucose. In other experiments, the conditions used during the 2-h labeling period with myo-[2-3H]inositol were varied. The following major observations were made in islets subsequently stimulated during the perifusion with 20 mM glucose. 3) Islets labeled with [3H]inositol in the presence of 2.75 mM glucose with or without 5.0 nM IL-1 responded with similar increases in PI hydrolysis and insulin output. 4) Compared to that with 2.75 mM glucose alone, labeling in the presence of 7 mM glucose alone was without any adverse effect on the subsequent PI and insulin responses of perifused islets to 20 mM glucose. 5) Labeling in the presence of 7 mM glucose plus 5.0 nM IL-1 resulted in a significant reduction in the subsequent PI and insulin responses. 6) These inhibitory effects of IL-1 were abolished if mannoheptulose was included during the 2-h incubation with 7 mM glucose plus 5.0 nM IL-1. 7) The diacylglycerol kinase inhibitor 1-monooleoylglycerol (100 microM) significantly restored insulin output after IL-1 exposure (with 7 mM glucose). 8) Similar to the results obtained with 7 mM glucose plus IL-1, incubation of islets with 8-10 mM glucose alone produced dose-dependent impairments of [3H]inositol efflux patterns and inositol phosphate accumulation. Insulin secretion was also impaired. These results demonstrate that IL-1 has glucose-dependent stimulatory and inhibitory effects on beta-cell function. Both effects appear to involve alterations in islet PI hydrolysis.

This article has been cited by other articles:

				P. O. T. Tran, C. E. Gleason, and R. P. Robertson Inhibition of Interleukin-1{beta}-Induced COX-2 and EP3 Gene Expression by Sodium Salicylate Enhances Pancreatic Islet {beta}-Cell Function Diabetes, June 1, 2002; 51(6): 1772 - 1778. [Abstract] [Full Text] [PDF]

				P. O. T. Tran, C. E. Gleason, V. Poitout, and R. P. Robertson Prostaglandin E2 Mediates Inhibition of Insulin Secretion by Interleukin-1beta J. Biol. Chem., October 29, 1999; 274(44): 31245 - 31248. [Abstract] [Full Text] [PDF]

				W. S. Zawalich, M. Bonnet-Eymard, and K. C. Zawalich Glucose-induced desensitization of the pancreatic beta -cell is species dependent Am J Physiol Endocrinol Metab, December 1, 1998; 275(6): E917 - E924. [Abstract] [Full Text] [PDF]

				C. H. Sorli, H.-J. Zhang, M. B. Armstrong, R. V. Rajotte, J. Maclouf, and R. P. Robertson Basal expression of cyclooxygenase-2 and nuclear factor-interleukin 6 are dominant and coordinately regulated by interleukin 1 in the pancreatic islet PNAS, February 17, 1998; 95(4): 1788 - 1793. [Abstract] [Full Text] [PDF]

				J. Vadakekalam, M. E. Rabaglia, and S. A. Metz Interleukin-1beta inhibits phospholipase C and insulin secretion at sites apart from KATP channel Am J Physiol Endocrinol Metab, November 1, 1997; 273(5): E942 - E950. [Abstract] [Full Text] [PDF]